Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Recorded changes
86,510 on record
Recorded policy changes, newest first| Recorded | Payer | Policy | Change |
|---|
| May 19, 2026 | CMS / Medicare | Digoxin Therapeutic Drug AssayNCD · NCD103 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Independent Diagnostic Testing Facilities- physician supervision and technician requirementsArticle · A54953 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Billing and Coding: Genetic Testing in Oncology: Specific TestsArticle · A59123 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Billing and Coding: Single Chamber and Dual Chamber Permanent Cardiac Pacemakers â Coding and BillingArticle · A54929 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative DiseaseArticle · A54927 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: MolDX: MGMT Promoter Methylation AnalysisArticle · A54896 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: MolDX: MGMT Promoter Methylation AnalysisArticle · A54895 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: MolDX: Genetic Testing for Hypercoagulability / ThrombophiliaArticle · A54893 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: MolDX: HLA-B*15:02 Genetic TestingArticle · A54881 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Billing and Coding: Additional Claim Documentation Requirements for Not Otherwise Classified (NOC) Drugs and Biological Products with Specific FDA Label IndicationsArticle · A54880 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Lipid TestingNCD · NCD102 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Thyroid TestingNCD · NCD101 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Billing and Coding: MolDX: Short Tandem Repeat (STR) Markers and Chimerism (CPT® codes 81265-81268)Article · A54832 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Billing and Coding: MolDX: Short Tandem Repeat (STR) Markers and Chimerism (CPT® codes 81265-81268)Article · A54830 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: MolDX: BRCA1 and BRCA2 Genetic TestingArticle · A54814 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: MolDX: HLA-DQB1 0602 Testing for NarcolepsyArticle · A54813 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Billing and Coding: Urine Drug TestingArticle · A54799 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Billing and Coding: MolDX: Targeted and Comprehensive Genomic Profile Testing in CancerArticle · A54795 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: Repetitive Transcranial magnetic Stimulation (rTMS) in Adults with Treatment Resistant Major Depression DisorderArticle · A54791 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: MolDX: Breast Cancer Assay: ProsignaArticle · A54790 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: Minimally-Invasive Surgical (MIS) Fusion of Sacroiliac (SI) JointArticle · A54781 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Billing and Coding: Cardiac Blood Pool Imaging (Multiple Gated Acquisition Scanning- MUGA, Ventriculography) When Performed in Conjunction with Cardiotoxic ChemotherapyArticle · A54768 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Billing and Coding: FDA approves Iluvien for Diabetic Macular EdemaArticle · A54750 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: Treatment of Varicose Veins of Lower ExtremitiesArticle · A54715 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Glycated Hemoglobin/Glycated ProteinNCD · NCD100 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: Treatment of Varicose Veins of Lower ExtremitiesArticle · A54714 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: Treatment of Varicose Veins of Lower ExtremitiesArticle · A54713 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Blood Glucose TestingNCD · NCD98 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: Treatment of Varicose Veins of Lower ExtremitiesArticle · A54710 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Billing and Coding: Germline testing for use of PARP inhibitorsArticle · A54689 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Billing and Coding: MolDX: FDA-Approved KRAS TestsArticle · A54688 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Billing and Coding: MolDX: BCR-ABLArticle · A54686 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Human Immunodeficiency Virus (HIV) Testing (Diagnosis)NCD · NCD53 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Billing and Coding: MolDX: Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy (ARVD/C) TestingArticle · A54685 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Billing and Coding: Coverage of Intravenous Immune Globulin for Treatment of Primary Immune Deficiency Diseases in the Home â Medicare Benefit Policy Manual, Chapter 15, 50.6Article · A54660 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Human Immunodeficiency Virus (HIV) Testing (Prognosis Including Monitoring)NCD · NCD46 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Urine Culture, BacterialNCD · NCD25 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Home Prothrombin Time/International Normalized Ratio (PT/INR) Monitoring for Anticoagulation ManagementNCD · NCD269 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: Immune Globulin Intravenous (IVIg)Article · A54647 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: Immune Globulin Intravenous (IVIg)Article · A54646 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: Immune Globulin Intravenous (IVIg)Article · A54645 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: Immune Globulin Intravenous (IVIg)Article · A54644 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Billing and Coding: Intravenous Immune Globulin (IVIg)-NCD 250.3Article · A54643 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: MolDX: Decipher Prostate Cancer Classifier AssayArticle · A54632 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: MolDX: Decipher Prostate Cancer Classifier AssayArticle · A54630 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: Molecular RBC PhenotypingArticle · A54617 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: Prolaris Prostate Cancer Genomic AssayArticle · A54616 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments for MolDX: Breast Cancer Assay: ProsignaArticle · A54611 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: MolDx: MGMT Promoter Methylation Analysis DL36113Article · A54607 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: Special Histochemical Stains and Immunohistochemical Stains, L36353Article · A54597 | Metadata changed |
|---|